|
Nurse
Practitioner World
|
Can home cooking be hazardous to your health?
(AP)
AP - Could your kitchen at home pass a restaurant inspection?
Botox maker to pay $600M to resolve investigation
(AP)
AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
New test seen as big advance in diagnosing TB
(AP)
AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.
Journal editors question sale of diet pill Meridia
(AP)
AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.
Benefits seen for high-risk women in ovary removal
(AP)
AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.
Double hand transplant patient shows new hands
(AP)
AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.
Study: Diet Drug Meridia May Boost Heart Risks
(Time.com)
Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke
For Bonobo Males, Mom Is the Best Wingman
(LiveScience.com)
LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.
Clinical Trials Update: Sept. 2, 2010
(HealthDay)
HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy
of ClinicalConnection.com:
Timer may help kids' bladder control problems
(Reuters)
Reuters - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.
Seniors Get Boost From Bad News About the Young
(HealthDay)
HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- Older people prefer to read
negative news stories about the young, possibly because it makes them feel
better about themselves, a new study suggests.
Bone drugs may raise risk of throat cancer
(AP)
AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.
Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in
Mice
(HealthDay)
HealthDay - WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to
treat high blood sugar in type 2 diabetics may hold some promise in the
prevention of tobacco-induced lung cancer, according to extremely
preliminary findings in a mouse study.
Safety groups find no Pampers link to rash cases
(Reuters)
Reuters - Two agencies investigating claims that Procter & Gamble Co's Pampers Dry Max gave children severe diaper rash reported Thursday that they have found no specific cause linking the diapers to rashes.
HIV discrimination case filed in China
(AP)
AP - A municipal court in central China has accepted the country's first lawsuit alleging work discrimination because of HIV status, state media reported Tuesday.
Diabetes drug may keep lung cancer at bay
(Reuters)
Reuters - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.
Health Tip: Coping With Hives
(HealthDay)
HealthDay - (HealthDay News) -- Hives are the result of an allergic reaction.
They typically go away without treatment, but can be an itchy
nuisance.
Abbott diet drug study renews calls for U.S. ban
(Reuters)
Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.